Western blotting revealed that BRI3BP overexpression upregulated ROCK1, ROCK2, PDGFB and p-MYPT1, whereas knockdown reduced their abundance (Supplementary Fig. S3), confirming the activation of the ROCK signaling pathway—a recognized driver of HCC progression13. The gene discussed is BRI3BP; the disease is hepatocellular carcinoma.